Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2003 1
2004 1
2005 1
2006 3
2008 1
2009 2
2010 4
2011 3
2012 4
2013 8
2014 7
2015 3
2016 5
2017 3
2018 3
2019 10
2020 13
2021 11
2022 12
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
The prevalence of MS in the United States: A population-based estimate using health claims data.
Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG; US Multiple Sclerosis Prevalence Workgroup. Wallin MT, et al. Among authors: langer gould a. Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15. Neurology. 2019. PMID: 30770430 Free PMC article.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH; HERMES Trial Group. Hauser SL, et al. Among authors: langer gould a. N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383. N Engl J Med. 2008. PMID: 18272891 Free article. Clinical Trial.
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T. Luna G, et al. Among authors: langer gould a. JAMA Neurol. 2020 Feb 1;77(2):184-191. doi: 10.1001/jamaneurol.2019.3365. JAMA Neurol. 2020. PMID: 31589278 Free PMC article.
Obesity, dieting, and multiple sclerosis.
Russell RD, Langer-Gould A, Gonzales EG, Smith JB, Brennan V, Pereira G, Lucas RM, Begley A, Black LJ. Russell RD, et al. Among authors: langer gould a. Mult Scler Relat Disord. 2020 Apr;39:101889. doi: 10.1016/j.msard.2019.101889. Epub 2019 Dec 9. Mult Scler Relat Disord. 2020. PMID: 31838309
Rituximab, MS, and pregnancy.
Smith JB, Hellwig K, Fink K, Lyell DJ, Piehl F, Langer-Gould A. Smith JB, et al. Among authors: langer gould a. Neurol Neuroimmunol Neuroinflamm. 2020 May 1;7(4):e734. doi: 10.1212/NXI.0000000000000734. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32358226 Free PMC article.
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.
Nelson LM, Wallin MT, Marrie RA, Culpepper WJ, Langer-Gould A, Campbell J, Buka S, Tremlett H, Cutter G, Kaye W, Wagner L, Larocca NG; United States Multiple Sclerosis Prevalence Workgroup. Nelson LM, et al. Among authors: langer gould a. Neurology. 2019 Mar 5;92(10):469-480. doi: 10.1212/WNL.0000000000007044. Epub 2019 Feb 15. Neurology. 2019. PMID: 30770422 Free PMC article. Review.
Multiple sclerosis, rituximab, and COVID-19.
Langer-Gould A, Smith JB, Li BH; KPSC MS Specialist Group. Langer-Gould A, et al. Ann Clin Transl Neurol. 2021 Apr;8(4):938-943. doi: 10.1002/acn3.51342. Epub 2021 Mar 30. Ann Clin Transl Neurol. 2021. PMID: 33783140 Free PMC article.
Multiple Sclerosis, Disease-Modifying Therapies, and Infections.
Langer-Gould AM, Smith JB, Gonzales EG, Piehl F, Li BH. Langer-Gould AM, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Oct 9;10(6):e200164. doi: 10.1212/NXI.0000000000200164. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37813594 Free PMC article.
Environmental and genetic risk factors for MS: an integrated review.
Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. Waubant E, et al. Among authors: langer gould a. Ann Clin Transl Neurol. 2019 Sep;6(9):1905-1922. doi: 10.1002/acn3.50862. Epub 2019 Aug 7. Ann Clin Transl Neurol. 2019. PMID: 31392849 Free PMC article. Review.
98 results